Brighter strengthens its financing with 672 TSEK through exercise of warrants.

The first exercise period for Brighter’s warrants of series TO4 is now completed. The company thereby strengthens its financing with 672 TSEK, representing 111,770 new shares.

- Unfortunately, the reminder with the subscription note was sent late to the shareholders this subscription period, says Truls Sjöstedt, Brighter's CEO and founder. This combined with the fact that a few of the larger institutes involved did not send the notice of the offer as planned, resulted in a very low subscription rate. We are in communication with these institutes working to achieve better results in the future. The next period is the TO3 series subscription period that runs from 11th of April to 25thof April. We will also send out more information on that by mail to all holders.

The next period for subscribing shares using TO4s is 25th of August to 8th of September 2018.

Those who subscribed in this exercise period have now obtained Interim Shares. Once the registration has been completed with the Swedish Companies Registration Office, conversion of the interim shares will automatically take place without further notice to the holders. The conversion is expected to occur within approximately one week from the completed registration. The interim shares will not be listed for trading.

Through this warrant exercise the number of shares and votes in Brighter will increase by 111,770 shares to a total of 66,160,000.

For terms and conditions of the Warrants, please visit:

För ytterligare information, vänligen kontakta:

Truls Sjöstedt, CEO
Telefon: +46 709 73 46 00

Ann Zetterberg, CFO
Telefon: +46 708 37 21 23 

Om Brighter AB
Brighter är ett svenskgrundat företag som från en unik IP-portfölj skapar lösningar för vårdens största problem: att förändra beteendet hos patienter. Kroniska sjukdomar som diabetes ökar snabbt och står för allt större del av vårdkostnaderna globalt. Brighters affärsmodell bygger på att många särintressen skapar värde för varandra, så kallad Multi-Sided Market Platform. Genom ökad tillgänglighet till valid hälsodata skapar Brighter värde för alla intressenter inom vårdsektorn: patienter och närstående, vårdgivare, forskning, läkemedelsindustri och samhälle.

Bolagets aktie är listad på NASDAQ OMX First North/BRIG. Brighters Certified Adviser på NASDAQ OMX First North är Remium Nordic Holding AB, +46 (0)8 – 454 32 50,

This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 16:00 CET on April 5, 2018.

About Us

Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of the most serious healthcare problems: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop™ - is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and close associates, healthcare providers, research, pharmaceutical industry and society. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter’s Certified Adviser is Eminova Fondkommission AB +46 (0)8 – 684 211 00,,


Documents & Links